Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 17, Issue 11, Pages 1045-1060
Publisher
Informa UK Limited
Online
2017-09-04
DOI
10.1080/14737140.2017.1374856
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome
- (2017) Zachary A. Corbin et al. JOURNAL OF NEURO-ONCOLOGY
- Intermittent oxaliplatin (oxali) administration and time-to-treatment-failure (TTF) in metastatic colorectal cancer (mCRC): Final results of the phase III CONcePT trial
- (2017) A. Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103.
- (2017) B. P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Manual Tactile Test Predicts Sensorimotor Control Capability of Hands for Patients With Peripheral Nerve Injury
- (2016) Hsiu-Yun Hsu et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer
- (2016) Stephen Sands et al. SUPPORTIVE CARE IN CANCER
- Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial
- (2015) Yasuo Hirayama et al. International Journal of Clinical Oncology
- Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study
- (2015) Eiji Oki et al. International Journal of Clinical Oncology
- Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
- (2015) Barthelemy Diouf et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy
- (2015) Collin Zimmerman et al. SUPPORTIVE CARE IN CANCER
- National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons
- (2015) Neil Majithia et al. SUPPORTIVE CARE IN CANCER
- Cancer treatment-related neuropathic pain: proof of concept study with menthol—a TRPM8 agonist
- (2015) M. T. Fallon et al. SUPPORTIVE CARE IN CANCER
- Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study
- (2015) Tulay Kus et al. SUPPORTIVE CARE IN CANCER
- Brentuximab vedotin: axonal microtubule’s Apollyon
- (2015) S Mariotto et al. Blood Cancer Journal
- Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry
- (2015) Floortje Mols et al. Journal of Cancer Survivorship
- Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy
- (2014) F. Streckmann et al. ANNALS OF ONCOLOGY
- Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy
- (2014) K S Courneya et al. BRITISH JOURNAL OF CANCER
- North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study
- (2014) Alexis D. Leal et al. CANCER
- Abstract LB-196: Sequencing symptom control: Results from the Alliance N08C1 and N08CA genetics of chemotherapy neuropathy trials.
- (2014) Andreas S. Beutler et al. CANCER RESEARCH
- Chemotherapy-induced neuropathy: A comprehensive survey
- (2014) N.C. Miltenburg et al. CANCER TREATMENT REVIEWS
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review
- (2014) Floortje Mols et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience
- (2014) Bhavana Bhatnagar et al. SpringerPlus
- CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel
- (2013) D. L. Hertz et al. ANNALS OF ONCOLOGY
- Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
- (2013) Ellen M. Lavoie Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy
- (2013) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)
- (2013) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial
- (2013) Ying Guo et al. SUPPORTIVE CARE IN CANCER
- Impact of Chemotherapy-Induced Peripheral Neuropathy on Treatment Delivery in Nonmetastatic Breast Cancer
- (2013) Rebecca M. Speck et al. Journal of Oncology Practice
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
- (2012) G. Cavaletti et al. ANNALS OF ONCOLOGY
- Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
- (2012) Zohreh Ghoreishi et al. BMC CANCER
- Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy
- (2012) Brandi N. Reeves et al. CANCER
- Neuroprotective effect of neurotropin on chronic oxaliplatin-induced neurotoxicity in stage II and stage III colorectal cancer patients: results from a prospective, randomised, single-centre, pilot clinical trial
- (2012) R. X. Zhang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Factors Exacerbating Peripheral Neuropathy Induced by Paclitaxel Plus Carboplatin in Non-small Cell Lung Cancer
- (2012) Kazuyoshi Kawakami et al. ONCOLOGY RESEARCH
- Impact of oxaliplatin-induced neuropathy: a patient perspective
- (2012) Barbara K. Bennett et al. SUPPORTIVE CARE IN CANCER
- Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial
- (2011) J. P. Durand et al. ANNALS OF ONCOLOGY
- Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)
- (2011) Lara E. Sucheston et al. BREAST CANCER RESEARCH AND TREATMENT
- Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment
- (2011) D R Pachman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Protective effect of Acorus calamus L. in rat model of vincristine induced painful neuropathy: An evidence of anti-inflammatory and anti-oxidative activity
- (2011) Arunachalam Muthuraman et al. FOOD AND CHEMICAL TOXICOLOGY
- The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen
- (2011) Masanori Nishioka et al. International Journal of Clinical Oncology
- Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
- (2011) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
- (2011) Philippe Moreau et al. LANCET ONCOLOGY
- Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel
- (2011) W.H. Xiao et al. NEUROSCIENCE
- Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy
- (2010) Wen-Yee CHAY et al. Asia-Pacific Journal of Clinical Oncology
- Organic cation transporter OCT/SLC22A and H+/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents
- (2010) Atsushi Yonezawa et al. BIOCHEMICAL PHARMACOLOGY
- Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
- (2010) S. Bringhen et al. BLOOD
- Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
- (2010) Guido Cavaletti et al. EUROPEAN JOURNAL OF CANCER
- Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study
- (2010) Meletios A. Dimopoulos et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice
- (2010) Jordi Bruna et al. EXPERIMENTAL NEUROLOGY
- Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study
- (2010) Keiichiro Ishibashi et al. International Journal of Clinical Oncology
- Physical Activity in Ovarian Cancer Survivors
- (2010) Clare Stevinson et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7
- (2010) Axel Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
- Pilot Trial of a Patient-Specific Cutaneous Electrostimulation Device (MC5-A Calmare®) for Chemotherapy-Induced Peripheral Neuropathy
- (2010) Thomas J. Smith et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Surviving Chemotherapy for Colon Cancer and Living with the Consequences
- (2010) Cindy Tofthagen JOURNAL OF PALLIATIVE MEDICINE
- A Trial to Assess the Efficacy of Glutamic Acid in Prevention of Vincristine-induced Neurotoxicity in Pediatric Malignancies: A Pilot Study
- (2010) Galila M. Mokhtar et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Chemotherapy-induced peripheral neurotoxicity
- (2010) Guido Cavaletti et al. Nature Reviews Neurology
- Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial
- (2010) A. Pace et al. NEUROLOGY
- A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA
- (2010) Debra L. Barton et al. SUPPORTIVE CARE IN CANCER
- Diagnostic approach to peripheral neuropathy
- (2009) UshaKant Misra et al. Annals of Indian Academy of Neurology
- Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity
- (2009) Paola Milla et al. ANTI-CANCER DRUGS
- Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity
- (2009) Johnson J. Liu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Bortezomib-induced painful neuropathy in rats: A behavioral, neurophysiological and pathological study in rats
- (2009) Cristina Meregalli et al. EUROPEAN JOURNAL OF PAIN
- Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity
- (2009) Francesca Lanzani et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study
- (2009) N. Attal et al. PAIN
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
- (2009) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- Thalidomide for treatment of multiple myeloma: 10 years later
- (2008) A. Palumbo et al. BLOOD
- Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
- (2008) A. A. Argyriou et al. BLOOD
- Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy
- (2008) Ravi D. Rao et al. CANCER
- A review on oxaliplatin-induced peripheral nerve damage
- (2008) Andreas A. Argyriou et al. CANCER TREATMENT REVIEWS
- Immune-mediated neuropathies in myeloma patients treated with bortezomib
- (2008) Sabrina Ravaglia et al. CLINICAL NEUROPHYSIOLOGY
- Peripheral nerve damage associated with administration of taxanes in patients with cancer
- (2008) Andreas A. Argyriou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
- (2008) Sherry Wolf et al. EUROPEAN JOURNAL OF CANCER
- Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel
- (2008) D. LOVEN et al. EUROPEAN JOURNAL OF CANCER CARE
- Oxaliplatin-Related Neurotoxicity: Interest of Calcium-Magnesium Infusion and No Impact on Its Efficacy
- (2008) Laurence Gamelin et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
- (2008) M. Jiang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms
- (2007) Anna-Liisa Kautio et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation